Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring—Preliminary Study

Abstract

(1) Background: Hormone-dependent events that occur throughout spermatogenesis during postnatal testis maturation are significant for adult male fertility. Any disturbances in the T/DHT ratio in male progeny born from females fertilized by finasteride-treated male rats (F0:Fin) can result in the impairment of testicular physiology. The goal of this work was to profile the testicular transcriptome in the male filial generation (F1:Fin) from paternal F0:Fin rats. (2) Methods: The subject material for the study were testis from immature and mature male rats born from females fertilized by finasteride-treated rats. Testicular tissues from the offspring were used in microarray analyses. (3) Results: The top 10 genes having the highest and lowest fold change values were mainly those that encoded odoriferous (Olfr: 31, 331, 365, 633, 774, 814, 890, 935, 1109, 1112, 1173, 1251, 1259, 1253, 1383) and vomeronasal (Vmn1r: 50, 103, 210, 211; Vmn2r: 3, 23, 99) receptors and RIKEN cDNA 5430402E10, also known as odorant-binding protein. (4) Conclusions: Finasteride treatment of male adult rats may cause changes in the testicular transcriptome of their male offspring, leading to a defective function of spermatozoa in response to odorant-like signals, which are recently more and more often noticed as significant players in male fertility.

1. Introduction

Without a doubt, the morphology and function of the male gonad are controlled by the hypothalamic–pituitary–gonad axis and locally produced androgens—testosterone (T) and more biologically active dihydrotestosterone (DHT) [1]. Transformation of T into DHT is catalyzed by 5a-reductase (5α-red) [2]. It was shown that in the male reproductive tract, the most common isoform of this enzyme is 5α-reductase type 2 (5α-red2) [3]. Inhibition of this enzyme by finasteride [4] has found application in clinical practice—in the therapy of prostate cancer, benign prostatic hyperplasia (BPH), and androgenetic alopecia (AGA; prematurely balding young men) [5,6]. In the 1990s, finasteride was introduced to medical care and was considered a safe drug, without any “side effects” on male fertility, and this view is still maintained among dermatologists [7,8]. However, there are many studies documenting contrary findings [9,10], a decrease in semen parameters [5,11,12], difficulties in fertilization [5], psychological problems such as reduced libido, orgasms, and erectile disorders [13], melancholy, and even suicidal thoughts [14]. Much more sensitive analysis has shown elevated sperm DNA fragmentation in patients treated with low doses of finasteride [15,16]. Studies with transmission electron microscopy revealed an altered sperm morphology resembling necrosis, while FISH (fluorescent in situ hybridization) data showed elevated frequencies of diploidy and sex chromosome disomy [17]. One year after the cessation of finasteride treatment, the meiotic pattern did not change, and elevated diploidy and sex chromosome disomy were still present; however, motility and sperm morphology were improved [17]. This so-called post-finasteride syndrome (PFS) was recently added to the list of genetic and rare diseases by the United States National Institutes of Health (NIH) [18,19].

In utero, dose-dependent exposure to finasteride induced permanent effects on androgen-sensitive end points, such as anogenital distance, nipple retention, and malformations of the male rat and rhesus monkey reproductive tracts (absence of prostate lobes, ectopic testes, small scrotum, small penis, hypospadias) [20,21]. Initially, it was suggested that there was still no documented full-term pregnancy or live birth from couples in which the man had received finasteride [15], so caution has been advised regarding the use of finasteride by male members of couples who are planning to have children [22]. Probably for these reasons, in 2015 in South Korea, a clinical study was conducted which proved that in 19 couples with documented paternal exposure to finasteride, 13 couples (68.4%) gave birth to normal full-term babies, and six cases (31.6%) resulted in spontaneous (n = 3) or artificial (n = 3) abortions [23]. In our previous study [24], we observed a low number of pups in the litters of female rats fertilized by finasteride-treated male rats. Therefore, we had to repeat the procreation process many times, and based on the literature, the reason was probably weak semen quality (as a “side-effect” of finasteride). We also observed the elimination of newborns by female rats (infanticide exists when mothers tend to kill deformed, sick, or weak young pups, only allowing the healthy ones to survive [25]). Moreover, in our experiment, female pups predominated in many litters. As was mentioned above, even a low dose of finasteride can exert a negative effect on sperm DNA integrity [15,16,17]; thus, the unequal distribution of sexes in the litters may have been caused by genetic changes in the spermatozoa chromosomes in the finasteride-treated rats. Possibly, finasteride-like endocrine disruptors (EDs), that mimic or block sex hormones, disrupt hormones homeostasis, and can negatively influence reproductive system development and function [26,27], could induce a transgenerational effect. For example, it was shown that pollutants present in semen could cause DNA oxidative damage [28], and molecular alterations in spermatozoa of men living in highly polluted areas are a result of the transgenerational effects of pollutants [29]. The treatment of male mice with dioxin (TCDD, 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin) produced alternations in the sex ratio of the filial generation [30], or the exposure of young men to environmental dioxins increased the probability of female births [31]. Additionally, the changed gender distribution strongly correlated with paternal dioxin exposure rather than maternal exposure [32]. Moreover, Anway et al. [33] showed that in utero exposure of rat fetuses to vinclozolin (an anti-androgenic endocrine disruptor) resulted in a decrease in the number of male pups per litter in subsequent F1–F4 generations, similar to our F1:Fin generation [24].

For the reasons described above, the goal of this work was to check if the testicular (without distinguishing cellular populations) transcriptome profile in the male filial generation (F1:Fin) from paternal rats (F0:Fin) receiving finasteride had changed.

2. Material and Methods

2.1. Animals

The study was conducted with albino Wistar rats in full accordance with Polish law and with the approval of the Local Ethics Committee for Scientific Experiments on Animals in Szczecin, Poland (Resolution No. 23/2010 dated 21 July 2010). Maximum efforts were made to minimize the number of animals and their suffering. The parental generation (F0) and their offspring (F1) were termed.

2.1.1. The Parental Generation

The parental generation was comprised of 12 female and 10 male rats (for mating purposes only). At the beginning of the experiment, the rats were 12 weeks old. During the 1 week adaptation period, the animals were housed in cages (3 females or 1 male per cage) in the Animal Facility of the Pomeranian Medical University. The room humidity was approximately 55%, and the air temperature 22 ± 2 °C. The lighting followed a 12/12 h day/night cycle. After the adaptation, the males were randomly divided into two groups (F0:Control, n = 4; and F0:Fin, n = 6). The six male rats of the F0:Fin group were administered finasteride (Proscar^®, MSD, Carmlington, UK) at 5 mg/kg/bw once a day (in the morning) as a small pellet of finasteride powder placed in bread. These animals willingly ate the pellets from the hand of the person performing the experiments. The paternal control group (F0:Control) received the same bread pellet but without finasteride. The dose of finasteride was the same as in an earlier investigation [34] and as described by others [35,36]. The period of finasteride treatment before mating lasted 56 days, in line with the results of our previous study, which had demonstrated pathomorphological changes in the seminiferous epithelium [34], and continued up to the end of the experiment (for 4–5 months). Once a week, the animals were weighed, and the finasteride dose was suitably adjusted. The mating of couples from the F0:Control and F0:Fin groups began at the same time to maintain the age of the parental animals for comparisons. Each mating pair was kept in one cage. After 1 week, the females were separated from the males, and each pregnant female rat was placed in a separate cage. Standard food and tap water were freely available.

2.1.2. The Filial Generation

The control offspring group (F1:Control) comprised male rats born from females fertilized by control male rats. The experimental offspring group (F1:Fin) comprised male rats born from females fertilized by the finasteride-treated male rats. The objective of the experiment was to take samples of the gonads from both F1 generations of rats at 14 and 90 postnatal days (PND). The 14-day-old offspring comprised 3 male rats from each group (F1:Control 14, F1:Fin 14); the 90-day-old offspring comprised the remaining 3 male rats from each of the groups (F1:Control 90, F1:Fin 90). This experimental model of gonad maturity is based on the fact that in the seminiferous epithelium of 7-day-old rats, there are only gonocytes and Sertoli cells, and during maturation (i.e., successive weeks of the experiment), other generations of germ cells occur within the seminiferous epithelium [24,37], which is why we selected gonads from 14-day-old rats. A completely mature gonad with spermatozoa production ability can be found in 3-month-old rats (90 days old) [24]. Following thiopental anesthesia (120 mg/kg bw, i.p., Biochemie GmbH, Wien, Austria), the testes from the offspring in each F1 group were resected and stored at −70 °C for further analysis.

2.2. Microarrays Analysis

2.2.1. RNA Isolation

Total RNA from each testis’ homogenates was isolated using a PARIS Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol, in four samples for subsequent microarray analysis: control rats at 14 days old (F1:Control 14), control rats at age 90 days old (F1:Control 90), finasteride-treated male parent rat offspring at age 14 days old (F1:Fin 14), finasteride-treated male parent rat offspring at age 90 days old (F1:Fin 90). Total RNA in a homogenate concentration of 100 ng/µL was used for the microarray experiment.

2.2.2. Affymetrix GeneChip Microarray and Data Analysis

A sense-strand cDNA generated from the total RNA was subjected to fragmentation and labeling using the GeneChip™ WT PLUS Reagent Kit (Thermo Fisher Scientific, Waltham, MA, USA) and then hybridized onto a Rat Gene 2.1 ST Array Strip. Hybridization, subsequent fluidics, and scanning steps were performed using an Affymetrix GeneAtlas™ System. Preliminary analysis and quality control of the scanned chips was performed using Affymetrix GeneAtlas Operating Software. The generated CEL files were subjected to further analysis using the R statistical language with the Bioconductor package and relevant libraries. For background correction, normalization, and summation of the raw data, the Robust Multiarray Averaging (RMA) algorithm implemented in the “affy” package of BioConductor was applied. Biological annotation was obtained from the “oligo” package of BioConductor in which the annotated data frame object was merged with the normalized data set, leading to a complete gene data table. The selection criteria for a significantly changed gene expression were based on an expression fold difference greater than |1.5|. Gene expression datasets fulfilling the cut-off criteria were visualized with scatter plots.

The DAVID Direct Database for Annotation, Visualization and Integrated Discovery was used to cluster the functional annotation of differentially expressed genes [38]. Gene symbols for up-regulated and down-regulated genes from each of the compared groups were loaded into DAVID using the “RDAVIDWebService” package of BioConductor. Functional annotation charts generated by DAVID with over-represented gene annotations are shown as bubble plots generated by the BACA package of BioConductor with the following criteria: p < 0.05, adjusted method = Benjamini, and minimal number of genes per group = 5. Groups of genes fulfilling these criteria are presented in a plot in which the bubble sizes indicate the number of genes represented in the corresponding annotation and the condition of these genes in terms of their downregulation and upregulation.

3. Results

3.1. Differential Gene Expression Profiles

Figure 1 and Figure 2. show a detailed analysis of the differentially expressed genes (DEGs; differentially expressed genes – fold change ≤ −1.5 (down-regulated genes) and fold change ≥ 1.5 (up-regulated genes)) in the testis from the control and experimental groups of rats at 14 days old (F1:Control 14, F1:Fin F14) and 90 days old (F1:Control 90, F1:Fin 90). The scatter plots in Figure 1A,B and Figure 2A,B show the four comparisons groups (F1:Fin 14 vs. F1:Control 14, F1:Fin 90 vs. F1:Control 90, F1:Control 14 vs. F1:Control 90, F1:Fin 14 vs. F1:Fin 90).

We found that a total of 22344 genes (in each comparison) were regulated in the immature rats F1:Fin 14 vs. F1:Control 14: 100 up-regulated, 107 down-regulated, and 22137 unchanged (Figure 1A). In the sexually mature individuals (F1:Fin 90 vs. F1:Control 90), 49 genes were up-regulated, 97 down-regulated, and 22198 unchanged (Figure 1B).

During physiological aging (Figure 2A,B), both in control (F1:Control) and experimental (F1:Fin) groups, a very similar number of genes were up-regulated (759 and 724, respectively), down-regulated (194 and 154, respectively) or unchanged (21391 and 21466, respectively).

3.2. List of the Top 10 Changed Genes

The top 10 genes with the highest and lowest fold changes from each of the four comparisons (F1:Fin 14 vs. F1:Control 14, F1:Fin 90 vs. F1:Control 90, F1:Control 14 vs. F1:Control 90, F1:Fin 14 vs. F1:Fin 90) are listed in

Table 1. Top 10 genes with the highest and lowest values of the fold expression change within the four individual comparison groups: F1:Control 14 vs. F1:Fin 14, F1:Control 90 vs. F1:Fin 90, F1:Control 14 vs. F1:Control 90, F1:Fin 14 vs. F1:Fin 90. Characteristic of gene/pseudogene function mainly from uniprot.org (accesse date: 24 June 2021) or ncbi.nlm.nih.gov (accesse date: 24 June 2021) and genecards.org (accesse date: 24 June 2021).

Comparison Group	Gene Symbol	Gene/Pseudogene Name and Its Major Characteristic/Function	Entrez Gene ID	Fold Change
F1:Fin 14 vs. F1:Control 14	Olfr365	olfactory receptor 365; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q8VFT2; accesse date: 24 June 2021).	405932	2.16
	Olfr814	olfactory receptor 814; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TRH4; accesse date: 24 June 2021).	405135	2.11
	Ugt2b5	UPD glucuronosyltransferase 2 family, (UGT); increase lipophilic substrates water solubility. Glucuronidation of steroid hormones. Cellular response to glucocorticoid, growth hormone, testosterone stimulus; estrogen metabolic process (https://www.uniprot.org/uniprot/P08542; accesse date: 24 June 2021).	266685	1.98
	Olfr774	olfactory receptor 774; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TRI5; accesse date: 24 June 2021).	405233	1.91
	Vmn1r211	vomeronasal 1 receptor 211; G-protein-coupled receptor. Pheromone receptor activity, pheromone binding, response to pheromone (https://www.uniprot.org/uniprot/Q8R266; accesse date: 24 June 2021).	494278	1.90
	Olfr935	olfactory receptor 935; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q8VG16; accesse date: 24 June 2021).	288868	1.89
	Olfr31	olfactory receptor 31; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/E9Q3K2; accesse date: 24 June 2021).	405403	1.85
	Krtap19-9b	keratin associated protein 19-9B; hair keratin filaments are embedded in matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft (https://www.uniprot.org/uniprot/Q99NG9; accesse date: 24 June 2021).	360626	1.83
	Zfp874a	zinc finger protein 874a or regulator of sex-limitation candidate 15; DNA-binding transcription factor activity. Regulation of transcription by RNA polymerase II (https://www.uniprot.org/uniprot/Q8BX23; accesse date: 24 June 2021).	286979	1.82
	Glipr1l1	GLI pathogenesis-related 1 like 1; binding of sperm to zona pellucida; a role in the binding between sperm and oocytes. Part of epididymosomes, membranous microvesicles which mediate the transfer of lipids and proteins to spermatozoa plasma membrane during epididymal maturation. Component of the CD9-positive microvesicles, found in the cauda region (https://www.uniprot.org/uniprot/Q9DAG6; accesse date: 24 June 2021).	299783	1.80
	Vmn2r23	vomeronasal 2, receptor 23; G-protein-coupled receptor activity (https://www.uniprot.org/uniprot/E9PXI5; accesse date: 24 June 2021).	308303	−1.78
	Rln1	relaxin 1; acts with estrogen to produce dilatation of the birth canal in many mammals. Hormone activity, signaling receptor binding. Modulation of G-protein-coupled receptor signaling pathway; developmental growth, mammary gland morphogenesis, negative regulation of apoptotic process, involved in nipple development, prostate gland growth, regulation of body fluid levels, regulation of cell population proliferation, regulation of nitric oxide-mediated signal transduction, spermatogenesis (https://www.uniprot.org/uniprot/P01347; accesse date: 24 June 2021).	25616	−1.78
	Bod1	biorientation of chromosomes in cell division 1; protein phosphatase inhibitor activity. Cell division, mitotic metaphase plate congression, mitotic sister chromatid biorientation and cohesion, centromeric, negative regulation of phosphoprotein phosphatase activity, protein localization to chromosome, centromeric region (https://www.uniprot.org/uniprot/Q6AYJ2, accesse date: 24 June 2021).	287173	−1.82
	Olfr633	olfactory receptor 633; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q8VF02; accesse date: 24 June 2021).	404844	−1.83
	Olfr1112	olfactory receptor 1112; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/A2ATA0; accesse date: 24 June 2021).	405559	−1.86
	Krt17	keratin 17—type I keratin; formation and maintenance of various skin appendages (by modulating TNF-alpha, Akt/mTOR, immune response in skin). Involved in tissue repair, a marker of epithelial ‘stem cells’. Constituent of cytoskeleton, hair follicle morphogenesis, intermediate filament-based process, keratinization, morphogenesis of epithelium, positive regulation of cell growth, hair follicle development, and translation (https://www.uniprot.org/uniprot/Q6IFU8, accesse date: 24 June 2021).	287702	−1.99
	Oas1g	2-5 oligoadenylate synthetase 1G; defense response to viruses, innate immune response, negative regulation of viral genome replication, regulation of ribonuclease activity (https://www.uniprot.org/uniprot/Q5MYX1; accesse date: 24 June 2021).	100910735	−2.01
	Dsg1c	desmoglein 1 gamma; component of intercellular desmosome junctions. Involved in homophilic cell adhesion via plasma membrane adhesion molecules. Calcium ion binding, gamma-catenin binding (https://www.uniprot.org/uniprot/Q7TSF0; accesse date: 24 June 2021).	291755	−2.06
	Akr1c19	aldo-keto reductase family 1, member C19; enzymatic activity, including steroid dehydrogenase activity. Involved in steroid metabolic process. 90% identity with NAD-preferring dehydrogenase for 17-β-hydroxysteroids and 9-hydroxyprostaglandins (https://www.uniprot.org/uniprot/D3ZEL2; accesse date: 24 June 2021).	307096	−2.13
	Gm4340	predicted gene 4340; RNA binding (https://www.uniprot.org/uniprot/L7N2C4; accesse date: 24 June 2021).	100043292	−2.40
F1:Fin 90 vs. F1:Control 90	Vmn1r103	vomeronasal 1 receptor 103; pheromone receptor activity, response to pheromones (https://www.uniprot.org/uniprot/K7N6X7; accesse date: 24 June 2021).	100312735	2.13
	Olfr1109	olfactory receptor 1109; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/A2AT96; accesse date: 24 June 2021).	405557	1.92
	Olfr1212	olfactory receptor 1212; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TR08; accesse date: 24 June 2021).	405579	1.89
	Chil3	chitinase-like 3; binds chitin and heparin. Has chemotactic activity. May play a role in inflammation and allergies. Enzymatic activity, chitin catabolic process, inflammatory response, polysaccharide catabolic process (https://www.uniprot.org/uniprot/O35744; accesse date: 24 June 2021).	295351	1.80
	Olfr1173	olfactory receptor 1173; olfactory receptor, odorant binding. G-protein-coupled receptor activity, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TR24; accesse date: 24 June 2021).	404329	1.79
	Vmn1r210	vomeronasal 1 receptor 210; pheromone receptor activity, response to pheromones (https://www.uniprot.org/uniprot/Q8R274; accesse date: 24 June 2021).	286957	1.77
	Gm15056	predicted gene 15056; lack of information (https://www.uniprot.org/uniprot/O88242; accesse date: 24 June 2021).	100504014	1.76
	Tmem161a	transmembrane protein 161A; cellular response to oxidative stress, cellular response to UV, negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage, positive regulation of DNA repair, response to retinoic acid (https://www.uniprot.org/uniprot/B1WC35; accesse date: 24 June 2021).	364535	1.75
	Wdr83os	WD repeat domain 83 opposite strand (preferred name protein: Asterix); component of the complex that facilitates multi-pass membrane proteins insertion into membranes, including ER. Involved in organization of the ER. Calcium ion homeostasis, ERAD pathway, ER overload response, post-embryonic development (https://www.uniprot.org/uniprot/Q5U2X6; accesse date: 24 June 2021).	288925	1.72
	Vmn1r50	vomeronasal 1 receptor 50; G-protein coupled receptor, putative pheromone receptor implicated in the regulation of social and reproductive behavior. Pheromone receptor activity, response to pheromone, sensory perception of chemical stimulus (https://www.uniprot.org/uniprot/Q9EP51; accesse date: 24 June 2021).	494267	1.71
	Hist1h2bn	histone cluster 1, H2bn; transcription regulation, DNA repair, DNA replication, and chromosomal stability. DNA binding, identical protein binding, protein heterodimerization activity. Antibacterial and antimicrobial immune response, defense response to Gram-positive bacterium, innate immune response in mucosa, nucleosome assembly (https://www.uniprot.org/uniprot/P10853; accesse date: 24 June 2021).	291157	−1.77
	Ptms	parathymosin; mediate immune function by blocking the effect of prothymosin alpha. Enzyme inhibitor activity, zinc ion binding, immune system processes (https://www.uniprot.org/uniprot/P04550; accesse date: 24 June 2021).	83801	−1.77
	Mrgpra6	MAS-related GPR, member A6—orphan receptor; G-protein-coupled receptor activity. A receptor for some neuropeptides, which are analgesic in vivo. Regulate nociceptor function and/or development, the sensation/modulation of pain (https://www.uniprot.org/uniprot/Q91ZC6; accesse date: 24 June 2021).	381886	−1.78
	Ormdl3	ORM1-like 3; cellular sphingolipid homeostasis, ceramide metabolic process, motor behavior, myelination, negative regulation of B cell apoptotic process, ceramide biosynthetic process, serine C-palmitoyltransferase activity; positive regulation of autophagy, protein localization to nucleus; regulation of ceramide biosynthetic process, smooth muscle contraction, sphingolipid and sphingomyelin biosynthetic process (https://www.uniprot.org/uniprot/Q6QI25; accesse date: 24 June 2021).	360618	−1.79
	Spin2d	spindlin family, member 2D; methylated histone binding. Regulates cell cycle, transcription, DNA-templated, gamete generation (https://www.uniprot.org/uniprot/B1B0R2; accesse date: 24 June 2021).	100504429	−1.81
	Olfr1383	olfactory receptor 1383; olfactory receptor, odorant binding. G-protein-coupled receptor, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TQT2; accesse date: 24 June 2021).	287232	−1.91
	Supt4a	suppressor of Ty 4A; regulates mRNA processing and transcription elongation, chromatin organization, mRNA processing, elongation, negative and positive regulation of transcription (https://www.uniprot.org/uniprot/P63271; accesse date: 24 June 2021).	20922	−1.91
	Gm5132	predicted gene 5132; DNA binding, protein heterodimerization activity. Chromatin silencing (https://www.uniprot.org/uniprot/L7MU04; accesse date: 24 June 2021).	333452	−1.91
	Rex2	RNA Exonuclease 2 Homolog; 3′-to-5′ exonuclease specific for small single-stranded RNA and DNA oligomers. DNA repair, replication, and recombination, RNA processing, and degradation. Resistance of cells to UV-C-induced cell death. A role in cellular nucleotide recycling (https://www.genecards.org/cgi-bin/carddisp.pl?gene=REXO2; accesse date: 24 June 2021).	104444	−2.04
	AF067061	cDNA sequence AF0670; lack of information (https://www.uniprot.org/uniprot/O70616; accesse date: 24 June 2021).	236546	−2.55
F1:Control 90 vs. F1:Control 14	Bod1	biorientation of chromosomes in cell division 1; DNA binding, protein phosphatase 2A binding, protein phosphatase inhibitor activity, cellular response to DNA damage stimulus, DNA repair, negative regulation of phosphoprotein phosphatase activity, replication fork processing (https://www.uniprot.org/uniprot/E9Q6J5; accesse date: 24 June 2021).	287173	3.57
	AY358078	cDNA sequence AY358078 (HN1-like protein); lack of information (https://www.uniprot.org/uniprot/Q6UY53; accesse date: 24 June 2021).	278676	3.09
	Gm8995	predicted gene 8995; lack of information (https://www.uniprot.org/uniprot/Q8C9P2; accesse date: 24 June 2021).	668139	2.97
	Klk1b5	Kallikrein 1-related peptidase b5; enzymatic activity, acting on carbon–nitrogen (but not peptide) bonds, proteolysis, regulation of systemic arterial blood pressure, zymogen activation (https://www.uniprot.org/uniprot/P15945; accesse date: 24 June 2021).	16622	2.94
	Idi2	isopentenyl-diphosphate delta isomerase 2; enzymatic activity, metal ion binding, cholesterol biosynthetic process, isopentenyl diphosphate biosynthetic process, isopentenyl diphosphate metabolic process, negative regulation of cholesterol biosynthetic process (https://www.uniprot.org/uniprot/Q8BFZ6; accesse date: 24 June 2021).	502143	2.70
	Olfr1259	olfactory receptor 1259; G-protein-coupled receptor activity, olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q8VEZ1; accesse date: 24 June 2021).	300581	2.64
	Krt17	keratin 17; described above.	287702	2.64
	Olfr331	olfactory receptor 331; G-protein-coupled receptor activity, olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q5NC44; accesse date: 24 June 2021).	405033	2.55
	Snora5c	small nucleolar RNA (snoRNAs), H/ACA box 5C; involved in RNA processing (https://www.ncbi.nlm.nih.gov/gene/677796; accesse date: 24 June 2021).	*	2.50
	C1rb	complement component 1, r subcomponent B; complement activation, classical pathway, innate immune response, zymogen activation, calcium ion binding, identical protein binding, serine-type endopeptidase activity (https://www.uniprot.org/uniprot/Q8CFG9; accesse date: 24 June 2021).	667277	2.43
	Trbj1-6	T cell receptor beta joining 1-6; participates in the antigen recognition. Initiates three major signaling pathways, the calcium, the mitogen-activated protein kinase (MAPK) kinase, and the nuclear factor NF-kappa-B (NF-kB) pathways (https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRBJ1-6; accesse date: 24 June 2021).	100125253	−2.18
	Vmn1r211	vomeronasal 1 receptor 211; described above.	171277	−2.21
	Vmn2r99	vomeronasal 2, receptor 99; G-protein-coupled receptor activity (https://www.uniprot.org/uniprot/H3BK37; accesse date: 24 June 2021).	680992	−2.36
	Gm10503	predicted gene 10503; lack of information (https://www.uniprot.org/uniprot/Q3UUQ9; accesse date: 24 June 2021).	100038436	−2.44
	Rpl35	ribosomal protein L35; component of the large ribosomal subunit. mRNA binding, ribonucleoprotein complex binding, structural constituent of ribosome, cellular response to UV-B, maturation of transcript, translation (https://www.uniprot.org/uniprot/P17078; accesse date: 24 June 2021).	296709	−2.54
	Olfr365	olfactory receptor 365; G-protein-coupled receptor activity. Olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q8VFT2; accesse date: 24 June 2021).	405932	−2.55
	Apol9a	apolipoprotein L 9a; lipid binding and transport, lipoprotein metabolic process (https://www.uniprot.org/uniprot/Q5XIB6; accesse date: 24 June 2021).	503164	−2.57
	Ssxb2	synovial sarcoma, X member B, breakpoint 2. A modulator of transcription, DNA-templated (https://www.uniprot.org/uniprot/Q8C5Z3; accesse date: 24 June 2021).	387132	−2.58
	Gm5592	predicted gene 5592; lack of information (https://www.uniprot.org/uniprot/Q3V0A6; accesse date: 24 June 2021).	434172	−2.72
	LOC102638448	40S ribosomal protein S7-like; lack of information (https://www.uniprot.org/uniprot/?query=LOC102638448&sort=score; accesse date: 24 June 2021).	102638448	−2.80
F1:Fin 90 vs. F1:Fin 14	Snora5c	small nucleolar RNA, H/ACA box 5C; Described above (https://www.ncbi.nlm.nih.gov/gene/677796; accesse date: 24 June 2021).	*	2.93
	5430402E10Rik	RIKEN cDNA 5430402E10 (odorant-binding protein 2); odorant binding, small molecule binding (https://www.uniprot.org/uniprot/Q9D3N5; accesse date: 24 June 2021).	71351	2.63
	Apol7b	apolipoprotein L 7b; lipid binding and transport, lipoprotein metabolic process (https://www.uniprot.org/uniprot/B1AQP7; accesse date: 24 June 2021).	278679	2.56
	Vmn2r3	vomeronasal 2, receptor 3; G-protein-coupled receptor activity, olfactory receptor activity (https://www.uniprot.org/uniprot/H3BJ88; accesse date: 24 June 2021).	502213	2.47
	Igkv1-110	immunoglobulin kappa variable 1-110; immune response (https://www.uniprot.org/uniprot/A0A0B4J1I0; accesse date: 24 June 2021).	381777	2.44
	Olfr1253	olfactory receptor 1253; G-protein-coupled receptor activity. Olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/A2AUA2; accesse date: 24 June 2021).	405091	2.32
	9030025P20Rik	RIKEN cDNA 9030025P20 gene; lack of information (https://www.uniprot.org/uniprot/Q3TV04; accesse date: 24 June 2021).	100041574	2.27
	Gsdmc2	gasdermin C2; constitutes the precursor of the pore-forming protein that causes membrane permeabilization and pyroptosis, binds to membrane lipids. Defense response to bacterium, intestinal epithelial cell development (https://www.uniprot.org/uniprot/Q2KHK6; accesse date: 24 June 2021).	331063	2.26
	Cpq	carboxypeptidase Q; enzymatic activity, liberation of thyroxine hormone, metal ion binding, peptide catabolic process, proteolysis, tissue regeneration (https://www.uniprot.org/uniprot/Q6IRK9; accesse date: 24 June 2021)	58952	2.25
	LOC102642621	uncharacterized LOC10264262; lack of information (https://www.uniprot.org/uniprot/?query=LOC102642621&sort=score; accesse date: 24 June 2021).	*	2.23
	Cyp2d9	cytochrome P450, family 2, subfamily d, polypeptide 9; enzymatic activity. Oxidation, heme, iron ion binding, steroid hydroxylase activity, arachidonic acid metabolic process, exogenous drug catabolic process, organic acid metabolic process, xenobiotic metabolic process (https://www.uniprot.org/uniprot/P11714; accesse date: 24 June 2021).	266684	−2.08
	Rln1	relaxin 1; described above (https://www.uniprot.org/uniprot/P01347; accesse date: 24 June 2021).	25616	−2.10
	Gm10503	predicted gene 10503; described above (https://www.uniprot.org/uniprot/Q3UUQ9; accesse date: 24 June 2021).	100038436	−2.11
	Olfr890	olfactory receptor 890; G-protein-coupled receptor activity. Olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TRD9; accesse date: 24 June 2021).	405511	−2.14
	Gm9805	predicted gene 9805; lack of information (https://www.uniprot.org/uniprot/O88242; accesse date: 24 June 2021).	100534296	−2.28
	Olfr1251	olfactory receptor 1251; G-protein-coupled receptor activity. Olfactory receptor, odorant binding, olfactory receptor activity. Sensory perception of smell (https://www.uniprot.org/uniprot/Q7TQZ3; accesse date: 24 June 2021).	300576	−2.36
	Gm5592	predicted gene 5592; described above (https://www.uniprot.org/uniprot/Q3V0A6; accesse date: 24 June 2021).	434172	−2.38
	Zfp455	zinc finger protein 455; regulation of transcription (https://www.uniprot.org/uniprot/G3V9J4; accesse date: 24 June 2021).	286979	−2.41
	Dsg1c	desmoglein 1 gamma. described above (https://www.uniprot.org/uniprot/Q7TSF0; accesse date: 24 June 2021).	291755	−2.73
	LOC102638448	40S ribosomal protein S7-like; described above (https://www.uniprot.org/uniprot/?query=LOC102638448&sort=score; accesse date: 24 June 2021).	102638448	−3.82

* no number in Entrez Gene ID database on 28 June 2021.

. It should be noted that the analyzed transcriptome came from testicular tissue that contains different, heterogenic populations of cells (e.g., Sertoli, Leydig, germ cell, etc.).

Among the four comparisons mentioned above, and from the listed 80 top genes, 17 genes encode odoriferous receptors (Olfr: 31, 331, 365 x2, 633, 774, 814, 890, 935, 1109, 1112 x2, 1173, 1251, 1259, 1253, 1383), 8 genes encode vomeronasal receptors (Vmn1r: 50, 103, 210, 211 x2; Vmn2r: 3, 23, 99) and 1 gene encodes RIKEN cDNA 5430402E10, which is also known as odorant-binding protein 2. These are the most extensively altered group of genes concerning G-protein-coupled receptors acting in the sensory perception of smell (odorant substances and pheromones).

Comparing the 14-day-olds (F1:Control 14 vs. F1:Fin 14), among the odoriferous receptors genes, five were up-regulated (Olfr365, Olfr814, Olfr774, Olfr935, Olfr31) and two down-regulated (Olfr633, Olfr1112), while among the vomeronasal receptors, one gene was up-regulated (Vmn1r211) and one down-regulated (Vmn2r23). Comparing the two groups of animals at 90 days old (F1:Control 90 vs. F1:Fin 90), among the odoriferous receptor genes, three genes were up-regulated (Olfr1109, Olfr1212, Olfr1173) and one was down-regulated (Olfr1383); three genes of vomeronasal receptor were up-regulated.

Additionally, microarray analysis shows age-related changes (14 days old vs. 90 days old) in transcript expression. In the control animals, two genes were up-regulated (Olfr1259, Olfr331) and three down-regulated (Olfr365, Vmn1r211, Vmn2r99). In the F1:Fin group of rats, three genes were up-regulated (Olfr1253, Vmn2r3, RIKEN cDNA 5430402E10) and one was down-regulated (Olfr890, Olfr1251).

In the comparisons—F1:Control 14 vs. F1:Fin 14 and F1:Control 90 vs. F1:Fin 90—among the genes directly related to fertility, changes were found in: Glipr1l1 (up-regulated; plays a role inter alia in the binding between sperm and oocytes), Rln1 (down-regulated; important, e.g., for prostate gland growth and spermatogenesis); and for genes indirectly related to fertility, changes were found in: Ugt2b5 (up-regulated; e.g., catalyzes the glucuronidation of endogenous steroid hormones, cellular response to testosterone stimulus, estrogen metabolic process that occur, e.g., in Sertoli cells), Akr1c19 (up-regulated; has steroid dehydrogenase activity), Vmn1r50 (up-regulated; putative pheromone receptor implicated in the regulation of social and reproductive behavior), Bod1 (down-regulated; need to proper cell division), Wdr83os (up-regulated; post-embryonic development), Ormdl3 (down-regulated; positive regulation of autophagy, e.g., elimination of residual bodies by Sertoli cells), Dsg1c (down-regulated; cell–cell adhesion, e.g., germ cells to Sertoli cells), Spin2d (down-regulated; regulation of cell cycle, gamete generation), Gm5132 (down-regulated; chromatin silencing), Tmem161a (up-regulated; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage, positive regulation of DNA repair).

Age-related (14- vs. 19-day-old) changes in gene expression (with the exception of receptors related to the perception of odors) in the F1:Control group were shown mainly in genes associated with immune defense: C1rb (up-regulated; complement activation, innate immune response), Trbj1-6 (down-regulated; essential for T cell growth and differentiation), regulation of transcription: Ssxb2 (down-regulated; acts as a modulator of transcription), and DNA repair: Bod1 (up-regulated; DNA repair), Rex2 (down-regulated; DNA repair, replication, recombination), and Idi2 (up-regulated, cholesterol biosynthesis) needed for steroidogenesis. Age-related changes in gene expression in the F1:Fin group showed some similarities in the genes associated with immune defense (but different genes than in the F1:Control rats): Igkv1-110 (up-regulated; immune response), Gsdmc2 (up-regulated; defense response to bacteria); and fertility: Rln1 (down-regulated; prostate gland growth, regulation of cell population proliferation, and spermatogenesis) and Dsg1c (down-regulated; cell–cell adhesion, e.g., germ cells to Sertoli cells). Therefore, many changed genes that were related to immune defense could probably be due to the fact that the interstitial tissue of the testes included many lymphatic vessels.

Subsequently, up-regulated and down-regulated genes (DEGs) from all experimental comparison groups were assigned a Gene Ontology term for the biological process, molecular function, and cellular component (GO term MF, BP, CC) per Benjamini method, as shown in Figure 3.

The bubble plots demonstrate that the greatest changes in gene expression correlate with age: in the control animals, this expression was mostly up-regulated, while in the finasteride-treated male offspring (F1:Fin), there were both up-regulation and down-regulation. When comparing the 14-day-old groups, F1:Fin 14 to F1:control 14, the expression was up-regulated, while in the 90-day-old groups, F1:Fin 90 vs. F1:Control 90, the expression was both up-regulated and down-regulated, but in a lower degree than in the age-dependent comparison.

4. Discussion

The microarray analysis of the testicular transcriptome profile shows that the top 10 genes with the highest and lowest changes in fold expression (F1:Fin 14 vs. F1:Control 14, F1:Fin 90 vs. F1:Control 90, F1:Control 14 vs. F1:Control 90, F1:Fin 14 vs. F1:Fin 90) were mainly genes associated with smelling (olfactory receptors, vomeronasal receptors).

It is known that inter alia sensory processing modulation induces reproductive behavior and endocrine changes. The microarray analysis shows that vomeronasal 1 receptor 50 (Vmn1r50 a G-protein coupled receptor) in mature male F1:Control 90 rats was up-regulated in comparison to the F1:Fin 90 group. This receptor is a putative pheromone receptor implicated in the regulation of social and reproductive behavior (https://www.uniprot.org/uniprot/Q9EP51; accesse date: 24 June 2021).

Across the animal kingdom, there are evolved sensory and behavioral strategies to identify suitable mating partners to guarantee reproductive success. It is known that odoriferous substances called pheromones carry species-specific and gender-specific information necessary for mating [39]. In this respect, reproductive substances play a very important role and generally have a negative effect on reproductive function after reaching a critical age. In more highly derived vertebrate clades (i.e., amniotes), a special male vomeronasal organ (Jacobson’s organ) evolved for the detection of pheromones [40]. Therefore, the changes observed by us in the transcriptome of F1:Control vs. F1:Fin in the rat offspring, in the context of pheromone receptors, could suggest some dysfunction in the evolutionary sexual behavior.

Furthermore, and more importantly for spermatozoa function, because our research material was testicular tissue, odoriferous substances are not only involved in the reproductive behavior of animals, but it has also been documented that olfactory-like signaling mechanisms are required for proper sperm physiology [41]. In the 1990s, olfactory receptor (OR) expression was uncovered in various ectopic tissues, including the testes and sperm cells [41]. Canine and human male germ cells demonstrate transcripts of about 20 OR genes, mostly during the late stages of spermatogenesis and during epididymal maturation [42], and ORs are placed in the midpiece and base of the flagellum of mature sperm [43]. Zhang et al. [44] used microarrays to detect 66 OR genes in mouse testes. Therefore, a hypothesis was put forward that the OR expression in male germ linage cells suggesting their potential implication in the control of sperm maturation, migration, and the chemical communication for sperm/egg fertilization [45], which is finding more and more supporting evidence [41,46,47].

One of the evidences that the reproductive potential of the animals treated with finasteride can be impaired is the publication by Kolasa-Wołosiuk et al. [24]. It was observed that the number of pups was lower in the litters of rats fertilized by finasteride-treated male rats, and repetition of the procreation process was needed. In this group of animals, infanticides and a gender shift in favor of females could have been the result of poor quality of sperm in the paternal generation. The results of the microarrays analysis of the testis of the male offspring evidenced a changed pattern in the expression of various olfactory receptors. This could indicate some physiological problems in the spermatozoa of those animals because inter alia olfactory receptors have been shown to mediate spermatozoa chemotaxis [47]. OR1D2 (Olfactory Receptor Family 1 Subfamily D Member 2, also known as hOR17-4) was the first odoriferous receptor expressed in the testes that was demonstrated to be involved in chemotaxis [46]. Ottaviano et al. [47] conducted a study on nine healthy normozoospermic adult males (34.6 ± 3.8 years) who had not been able to have children in the last 3 years. In the control group of men who already had children, this study showed a significantly higher percentage of spermatozoa had migrated toward capillaries filled with bourgeonal (the most potent known agonist of OR1D2) compared to the nine healthy childless men. Thirteen single nucleotide polymorphisms of the OR1D2 gene in the men suffering unexplained infertility were documented. Therefore, theoretically, idiopathic infertility could be caused by the improper action of odoriferous receptors [47].

Spermatozoa traveling to the oocyte are guided along the female internal reproductive tract by thermotaxis, chemotaxis, and molecules enhancing chemoattraction [48]. The sources of biochemically active biomolecules that facilitate the spermatozoa forward motility, sperm selection/survival, and oocyte–sperm communication are the ovaries (the oocyte and cells of cumlus oophorus secrete into the follicular fluid sperm chemoattractants) [49] and the female reproductive tract [41,46,50]. Moreover, the ovarian follicles could also communicate with the spermatozoa prior to ovulation [51]. Therefore, follicular fluid as well as oviduct fluid not only provide a proper microenvironment and nutritional status for the development of oocytes and then their transport, but also afford sperm hyperactivation (needed for proper movement), their navigation via the mucus-filled narrow labyrinthine lumen of the fallopian tube, and finally, penetration of the zona pellucida to cross-talk with the oocyte [52]. It was documented that the movement pattern of spermatozoa has been controlled differently by the composition of metabolites in the fluid milieu present in the female reproductive tract [53]. Additionally, some critical regulators secreted from the ovary and reproductive tract play a crucial role in determining oocyte–sperm interaction and communication in a dose-dependent manner [54]. Undoubtedly, many studies have presumed the involvement of odorant-like signaling in the initiation of spermatozoa hyperactivation; however, only a few have been identified to date [53]. In the light of the above-described reports, the changes that have been demonstrated in this present study in the transcriptome of F1:Fin rats, in the context of olfactory receptors and vomeronasal receptors, may assume impaired spermatozoa physiology (chemotaxis, swimming speed, hyperactive flagella beating, cross-talk with oocyte). Our previous study showed changes in the severity of apoptosis in the seminiferous epithelium of rats from F1:Fin vs. F1:Control [24], possibly related to the fact that some olfactory receptors are also involved in specific functions underlying sperm maturation and transport them between Sertoli cells from the basal membrane to the seminiferous tubular lumen, in which reduced expression has linked them to male infertility in azoospermic patients with spermatocyte development arrest [55,56].

The Benjamini method of transcriptome analysis shows that in the F1:Fin male offspring, the molecular function and the cellular component were down-regulated with time, which is likely why we previously had problems with the fertilization of female rats when using finasteride-treated male rats [24]. Certainly, the question “Can spermatozoa smell?” is still open, and new discoveries will probably unravel the mysteries of odoriferous and vomeronasal receptor expression in mammalian sperm. The nature and source of such potential chemical guideposts, as well as the molecular mechanisms underlying chemically induced changes in sperm motility, are still unknown.

The literature data on the effect of finasteride on the expression of androgen receptors (AR) are contradictory [57,58]. However, the discrepancies can be explained by the different types of tested tissues and by biochemical factors. Additionally, the polymorphisms of the AR genes have been described [59], among which those that increase the probability of the occurrence of the post-finasteride syndrome or androgenic alopecia have been identified [60]. Our previous work [61] showed that in the liver obtained from the offspring derived from treated with finasteride paternal generation, expression of AR on mRNA level was statistically reduced only in adult F1:Fin rats.

Our work focuses on the description of the observed changes. However, based on the literature, we can describe the possible mechanisms that lead to their formation. Especially that the finasteride-induced epigenetic changes in gene expression, including changes of androgen receptors expression, increased histone acetylation and methylation, result in undesirable biological effects [62]. Some papers [63] indicate that the likely mechanism of transgenerational action of finasteride can be connected with CpG methylation in the 5α-reductase type 2 gene and consequently change its protein expression in prostatic tissue. Traish [62], based on a literature review, proposed the following steps of finasteride induced epigenetic changes: (i) finasteride binds to the 5α-red2 with high affinity; (ii) at the same time, finasteride dissociates very slowly from 5α-red2; (iii) turnover of the 5α-red2 is short; (iv) in this situation, it may take up to 4–8 weeks for the physiological level of 5α-DHT to recover; (v) the key endocrine pathway (including hypothalamic-pituitary axis) is disrupted and prolonged 5α-DHT deficiency can induce changes; (vi) silencing of 5α-red2 expression and altering expression and androgen function is likely; (vii) additionally, finasteride leads to an inhibition of neurosteroid biosynthesis, which may exacerbate epigenetic changes. Thus, epigenetic modifications induced by finasteride may result in suppression not only of the hypothalamic–pituitary–testicular axis, irreversible suppression of 5α-reductase expression, off-target suppression of androgen receptor action, but also effects on brain regions that regulate sexual function and mood [62].

There are no studies on the direct effect of finasteride/DHT deficiency on the expression of odorant receptors. However, it was documented that disruption of a critical endocrine pathway may lead to induced epigenetic changes in response to 5α-DHT deficiency, which may contribute to the silencing of the 5α-red2 gene expression and changes in AR expression and function [62]. In seminiferous epithelium, both Sertoli, as well as germ cells, express androgen receptors [64,65], so probably, the changed AR expression in the testes of F1:Fin rats (as we observed this change in the liver of these rats [61]) could result in improper physiology of seminiferous epithelium or spermatozoa.

As with any scientific publication, our work also has limitations. First of all, the transcriptome was evaluated in the testicular tissue without distinguishing cellular populations (Leydig, Sertoli, germ cells, etc.) Our primary focus is on the changes observed in the offspring of paternal rats administered finasteride. We have no evidence of what mechanisms led to these changes. Therefore, we can only make assumptions and plan research on these mechanisms in the future. We do not have marked the level of protamination of sperm DNA, an important marker of stabilization of chromatin structure and maturity of sperm; we will try to perform such analyses in the future.

Among other genes associated with male fertility that were up-regulated or down-regulated between the F1:Fin vs. F1:Control rats, we found the genes that are involved in: (i) binding between sperm and oocytes; (ii) prostate gland growth and spermatogenesis controlled by Sertoli cells; (iii) cellular response to testosterone stimulus and estrogen metabolic process (that occur, e.g., in Sertoli cells); (iv) proper cell division/cell cycle (gamete generation), chromatin silencing, regulation of intrinsic apoptotic signaling pathway in response to DNA damage; (v) regulation of autophagy, e.g., during the elimination of residual bodies by Sertoli cells; and (vi) cell–cell adhesion, e.g., germ cells to Sertoli cells. Thus, it can be hypothesized that the rat offspring in the F1:Fin group may be characterized by impaired spermatogenesis controlled and regulated by Sertoli cells in response to steroid hormones, spermatozoa physiology, or some under-development in the male reproductive system or other organs. Additionally, during aging, the transcriptome profile for genes encoding proteins involved in the immune response was also changed, but these genes were different in the F1:Control group than in the F1:Fin group.

5. Conclusions

Finasteride treatment of male adult rats may cause changes in the testicular transcriptome profile of their offspring, leading to a defective function of germinal and somatic cells (Leydig, Sertoli cells, etc.) in response to odorant-like signals, which are recently more and more often noticed as significant players in male fertility.